Back

Unique proteomic signature of JCPyV-infected human astrocytes: from cells to extracellular vesicles

Oberholster, L.; Mathias, A.; Perriot, S.; Blaser, E.; Canales, M.; Jones, S.; Culebras, L.; Gimenez, M.; Kaynor, G. C.; Sapozhnik, A.; Richetin, K.; Goelz, S.; Du Pasquier, R.

2023-04-13 neuroscience
10.1101/2023.04.11.536379 bioRxiv
Show abstract

JC polyomavirus (JCPyV) is an opportunistic virus that remains in a latent state in the kidneys of more than half of the human adult population. In rare cases of severe immune suppression, the virus is able to establish a lytic infection of glial cells in the brain, resulting in a debilitating, demyelinating disease known as progressive multifocal leukoencephalopathy (PML). Because of the exceptional species and tissue specificity of the virus, appropriate models of JCPyV infection in the brain are lacking, thus hampering progress towards the development of novel antiviral strategies and biomarkers of disease activity. While PML has traditionally been characterized as a lytic infection of oligodendrocytes, more recent findings suggest an important role for astrocytes during the initial stages of disease. Here, using human induced pluripotent stem cell (hiPSC) derived-astrocytes coupled with a multiparametric approach, we show that 1. JCPyV readily infects and replicates in astrocytes, 2. JCPyV strongly dysregulates the cell biology and 3. these findings adequately reflect ex vivo findings. We perform an in-depth characterization of the effect of JCPyV on the cell proteome over time, demonstrating a strong dysregulation of the cell cycle and activation of the DNA damage response. Furthermore, we show that the proteomic signature observed for infected astrocytes is extended to excreted vesicles, underlining their potential to gain valuable insights into JCPyV propagation in the brain.

Matching journals

The top 6 journals account for 50% of the predicted probability mass.

1
EMBO Molecular Medicine
85 papers in training set
Top 0.1%
19.6%
2
Nature Communications
4913 papers in training set
Top 13%
12.6%
3
Cell Reports
1338 papers in training set
Top 3%
9.2%
4
iScience
1063 papers in training set
Top 3%
4.4%
5
PLOS Pathogens
721 papers in training set
Top 3%
4.0%
6
Nucleic Acids Research
1128 papers in training set
Top 5%
3.9%
50% of probability mass above
7
Journal of Neuroinflammation
50 papers in training set
Top 0.2%
3.6%
8
PLOS Biology
408 papers in training set
Top 4%
3.3%
9
Proceedings of the National Academy of Sciences
2130 papers in training set
Top 25%
2.6%
10
Advanced Science
249 papers in training set
Top 8%
2.1%
11
Communications Biology
886 papers in training set
Top 5%
2.1%
12
Scientific Reports
3102 papers in training set
Top 50%
2.1%
13
Science Advances
1098 papers in training set
Top 14%
1.9%
14
eLife
5422 papers in training set
Top 39%
1.8%
15
Viruses
318 papers in training set
Top 3%
1.5%
16
Cell Reports Medicine
140 papers in training set
Top 4%
1.5%
17
Cell Reports Methods
141 papers in training set
Top 3%
1.2%
18
EMBO reports
136 papers in training set
Top 4%
1.2%
19
Journal of Medical Virology
137 papers in training set
Top 4%
0.8%
20
Developmental Cell
168 papers in training set
Top 11%
0.8%
21
mBio
750 papers in training set
Top 11%
0.8%
22
Molecular & Cellular Proteomics
158 papers in training set
Top 2%
0.8%
23
eBioMedicine
130 papers in training set
Top 5%
0.7%
24
The EMBO Journal
267 papers in training set
Top 5%
0.7%
25
Heliyon
146 papers in training set
Top 9%
0.5%
26
Frontiers in Immunology
586 papers in training set
Top 10%
0.5%
27
Emerging Microbes & Infections
74 papers in training set
Top 2%
0.5%
28
Frontiers in Cell and Developmental Biology
218 papers in training set
Top 12%
0.5%
29
Cells
232 papers in training set
Top 9%
0.5%